New hip liner under Long-Term watch: will it hold up?
NCT ID NCT05587244
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is following 202 people who received a special hip liner during hip replacement surgery. The goal is to see how long the liner lasts and whether it causes any problems over time. Participants are adults aged 18 to 80 with conditions like arthritis or hip fractures. The study will track device survival and any side effects for up to 10 years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
G7 Freedom Constrained Vivacit-E Acetabular Liners (a medical device used in hip replacement surgery)
What this could lead to
If successful, this study could confirm that this hip liner is safe and works well over the long term, helping people with hip problems get a reliable replacement option.
What could go wrong
This is an observational follow-up study, not a randomized trial, so results may not apply to everyone. The device could still fail or cause complications like dislocation or infection over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jersey City Medical Center, Inc
Livingston, New Jersey, 07039, United States
-
Medical City Plano
Plano, Texas, 75075, United States
-
TOA Research Foundation
Knoxville, Tennessee, 37923, United States
-
The Ohio State University
Columbus, Ohio, 43201, United States
-
The University of Texas Health Science Center of Houston
Houston, Texas, 77030, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35205, United States
-
University of Florida Board of Trustees
Gainesville, Florida, 32611, United States
-
University of Southern California
Los Angeles, California, 90033, United States
-
University of Utah
Salt Lake City, Utah, 84108, United States
-
West Virginia University
Morgantown, West Virginia, 26506, United States